Unfortunately TRXC has not set a good precedent for young robotic surgery companies. Investors have been pouring tons of $ into that company for years and they have been getting killed. With that and the fact that most institutional investors can't touch Titan because of restrictions we are left with very few options.
I still say we take on a little debt. Maybe 15-20 million. Just something that gets us well into Q1, if not Q2 of next year. We'll be very close to major milestone announcements at that point which Mr. Market will have to consider. It's easy to ignore us now when were several months out from a hint of major developments. But come next year and news could hit the wire at anytime I don't believe for a minute we would remain stagnant.
I know the risk is putting our IP in jeopardy. What about offering Randall up as collateral? If we fail they get to keep him.
News 
Market Data 
Discover 
AI
